-
TMEM16F Lipid Scrambling Modulates Ferroptosis and Tumor Imm
2026-05-14
Yang et al. reveal TMEM16F as a plasma membrane lipid scramblase that suppresses ferroptosis by reducing membrane tension through phospholipid redistribution. Their work uncovers how targeting lipid scrambling can sensitize tumors to ferroptotic death and potentiate immune rejection, highlighting new avenues for cancer therapy.
-
Copper-Catalyzed Tandem Radical Cyclization for Thioazafluor
2026-05-14
This study introduces a copper-catalyzed tandem radical cyclization of N-tosyl-8-ethynyl-1-naphthylamines, enabling efficient synthesis of sulfur/nitrogen-doped fluoranthene derivatives. The resulting thioazafluoranthenes display notable fluorescence properties, offering new tools for optoelectronic research and materials chemistry.
-
D-Luciferin Potassium Salt: Illuminating Neuroimmune Pain Pa
2026-05-13
Explore how D-Luciferin (potassium salt) advances in vivo bioluminescence imaging for neuroimmune pain research. This in-depth analysis connects substrate chemistry with the latest insights into central mechanisms of pancreatic cancer-induced pain.
-
TCAIM Controls Mitochondrial Metabolism via OGDH Protein Red
2026-05-13
Wang et al. (2025) reveal that the mitochondrial DNAJC co-chaperone TCAIM specifically binds to and reduces the protein levels of a-ketoglutarate dehydrogenase (OGDH), modulating TCA cycle activity and cellular metabolism. This study uncovers a novel post-translational regulatory mechanism distinct from classical chaperone-mediated protein folding, with broad implications for understanding metabolic control and proteostasis.
-
Antimycin A4: Applied Workflows for ATP-Citrate Lyase Inhibi
2026-05-12
Leverage Antimycin A4’s dual inhibition of ATP-citrate lyase and mitochondrial respiration to dissect metabolic dependencies in cell-based and biochemical assays. This guide translates advanced reference workflows and troubleshooting tips into actionable protocols, ensuring reproducibility and data clarity for energy metabolism and lipid biosynthesis research.
-
Spermine in Cellular Metabolism Research: Protocols & Innova
2026-05-12
Spermine, a central endogenous polyamine, is revolutionizing cellular metabolism and ion channel regulation by enabling precise modulation of inward rectifier potassium channels. Discover practical workflows, troubleshooting strategies, and the latest innovations—bridging foundational ion channel biology to advanced viral egress research—with Spermine (SKU C4910) from APExBIO.
-
LMO2–LDB1 Axis Drives AML Progression via Apoptosis Regulati
2026-05-11
This study elucidates the oncogenic role of the LMO2/LDB1 transcriptional complex in acute myeloid leukemia (AML), demonstrating that LDB1 is essential for leukemic cell proliferation and survival through regulation of apoptosis-related genes. These findings highlight the LMO2/LDB1 axis as a promising therapeutic target and provide a framework for future epigenetic and DNA replication fidelity studies in AML.
-
Firefly Luciferase mRNA (ARCA, 5-moUTP): Applied Protocols &
2026-05-11
Firefly Luciferase mRNA (ARCA, 5-moUTP) from APExBIO sets a new benchmark in bioluminescent reporting, powering robust gene expression, cell viability, and in vivo imaging assays. Its advanced modifications enable reliable, high-sensitivity workflows, while recent innovations in mRNA-LNP handling further boost delivery and assay reproducibility.
-
Applied Workflows with Gap26 Connexin 43 Mimetic Peptide
2026-05-10
Gap26 empowers precise modulation of intercellular calcium signaling and ATP release in complex 3D cell models. This article translates cutting-edge bench protocols and troubleshooting strategies to maximize experimental reproducibility and insight when targeting connexin 43-driven pathways.
-
Gut Dysbiosis Drives Prostate Cancer via NF-κB-IL6-STAT3 Axi
2026-05-09
Zhong et al. (2022) reveal that antibiotic-induced gut dysbiosis accelerates prostate cancer progression and docetaxel resistance through activation of the NF-κB-IL6-STAT3 signaling axis. Their work identifies Proteobacteria enrichment and intratumoral LPS as key drivers, highlighting STAT3 as a mechanistic target with translational implications for cancer biology.
-
Adenosine Triphosphate in Cellular Metabolism Research Workf
2026-05-08
Adenosine triphosphate (ATP) is essential for dissecting metabolic pathways and purinergic signaling in modern biomedical research. This guide delivers stepwise protocols, real-world troubleshooting, and strategic insights—leveraging the latest findings on mitochondrial regulation—to help researchers maximize the value of ATP from APExBIO in advanced experimental systems.
-
CXCL1-CXCR2 Signaling in NTS Microglia Drives Pancreatic Can
2026-05-08
This study reveals that CXCL1-CXCR2 signaling in the nucleus tractus solitarii (NTS) critically mediates microglial activation, driving central sensitization and pain in pancreatic cancer. By dissecting neuroimmune interactions in the brainstem, these findings open new avenues for targeted analgesic strategies in cancer-induced visceral pain.
-
CX-4945 (Silmitasertib): Applied CK2 Inhibition in Bench Res
2026-05-07
CX-4945 (Silmitasertib) enables precise and potent interrogation of CK2-regulated signaling, offering unique advantages for both oncology and virology workflows. This article distills protocol optimizations, troubleshooting strategies, and key insights from recent mechanistic studies—empowering researchers to harness CK2 inhibition for advanced pathway mapping and host-directed antiviral investigations.
-
5-(N,N-dimethyl)-Amiloride Hydrochloride: Selective NHE1 Inh
2026-05-07
5-(N,N-dimethyl)-Amiloride hydrochloride is a potent, selective inhibitor of Na+/H+ exchanger isoforms NHE1-3, widely used in ion transport and intracellular pH regulation research. Its robust activity profile and benchmarked selectivity enable reliable modeling of ischemia-reperfusion injury protection and cardiac contractile dysfunction. APExBIO provides this compound as SKU C3505 for research use only.
-
GSK-923295 and Mitotic Fidelity: Advanced Insights for CENP-
2026-05-06
Discover how GSK-923295, a potent CENP-E inhibitor, advances cancer research through precise modulation of mitotic fidelity. This in-depth analysis integrates recent findings on centromere biology with actionable guidance for next-generation assay design.